Methods: We reviewed clinic records of all patients above 16 years of age with advanced CKD (Cockcroft-Gault stage III-V), who were diagnosed with tuberculosis from January 2015 to December 2016, at District Chest Clinic, Anuradhapura.
Out of 69 aCKD patients, Tuberculin Skin Test (TST) results were available for 43 patients, which was positive in 19 (44.19%) and negative in 24 (55.81%). In non-aCKD patients, TST results were available for 256 patients, where 153 (59.76%) gave positive results, and 103 (40.23%) gave negative results. Fisher's Exact Test revealed a statistical significance of TST negativity in the presence of aCKD in this study population (P = 0.05).
Conclusion:
Pulmonary tuberculosis was commoner than extrapulmonary tuberculosis in all categories. CNS was the common extrapulmonary site in aCKD, compared to lymph node involvement in nonaCKD. TST was significantly negative in aCKD. Results: Out of total 475 patients registered in tuberculosis clinic during the study period, 333 (70%) had PTB. aCKD was noted in 51 (15%) of them (41(80%) bacteriologically confirmed; 10 clinically diagnosed), while 282 (250 (89%) bacteriologically confirmed; 32 clinically diagnosed) did not have aCKD. Sputum direct smear positivity in relation to aCKD was statistically not significant (X2 = 2.674, P = 0.102).
Cough and loss of appetite were the commonest symptoms in both groups, who showed a similar symptom profile (Figure 1 ). Mean CXR severity score (Ralph AP, et al. BMJ 2010) , in aCKD was 55.3, compared to 25.1in non-aCKD (t = 14.8, P = 0.469).
In bacteriologically confirmed PTB in aCKD, 16 (39.02%) had sputum grade +1 positivity and 7 (17.07%) had scanty positivity on direct examination for acid fast bacili (AFB). In contrast, in non-aCKD group 97 (38.8%) had +3 positivity and 68 (27.2%) had +2. Significantly low sputum positivity is noted in aCKD (X 2 = 6.9247, 0.008).
Cure rate of PTB was 90% in aCKD, compared to 98% in non-aCKD. Death rates were significantly high in aCKD in relation to both bacteriologically confirmed PTB (3 each; X 2 = 6.1588, P = 0.013) and clinically diagnosed PTB (2 each; X 2 = 4.0884, P = 0.043). (Table 1) Conclusion: Symptomatology in PTB was not different in aCKD, compared to non-aCKD group. However sputum AFB direct examination revealed significantly low mycobacterial load in aCKD patients. PTB in aCKD had a comparatively lower cure rate (90% vs 98%) with significantly higher death rates.
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